fingolimod "teva" 0,5 mg kapsler, hårde
teva gmbh - fingolimodhydrochlorid - kapsler, hårde - 0,5 mg
fingolimod "zentiva" 0,5 mg kapsler, hårde
zentiva k.s. - fingolimodhydrochlorid - kapsler, hårde - 0,5 mg
fingolimod "glenmark" 0,5 mg kapsler, hårde
glenmark pharmaceuticals nordic ab - fingolimodhydrochlorid - kapsler, hårde - 0,5 mg
fingolimod mylan
mylan ireland limited - fingolimod hydrochlorid - multipel sklerose, recidiverende-remitterende - immunosuppressiva - indicated as single disease modifying therapy in highly active relapsing remitting multiple sclerosis for the following groups of adult and paediatric patients aged 10 years and older:patients with highly active disease despite a full and adequate course of treatment with at least one disease modifying therapy (for exceptions and information about washout periods see sections 4. 4 og 5. 1)orpatients med hurtigt udviklende alvorlige relapserende remitterende multipel sklerose, der er defineret ved 2 eller flere invaliderende tilbagefald i et år, og med 1 eller flere gadolinium øge læsioner på hjernen mr-scanning eller en betydelig stigning i t2 læsion belastning i forhold til en tidligere de seneste mr -.
fingolimod mylan
mylan ireland limited - fingolimod hydrochlorid - multipel sklerose, recidiverende-remitterende - immunosuppressiva - indicated as single disease modifying therapy in highly active relapsing remitting multiple sclerosis for the following groups of adult and paediatric patients aged 10 years and older: patients with highly active disease despite a full and adequate course of treatment with at least one disease modifying therapy (for exceptions and information about washout periods see sections 4. 4 og 5. 1) or patients with rapidly evolving severe relapsing remitting multiple sclerosis defined by 2 or more disabling relapses in one year, and with 1 or more gadolinium enhancing lesions on brain mri or a significant increase in t2 lesion load as compared to a previous recent mri.
paxlovid
pfizer europe ma eeig - nirmatrelvir, ritonavir - covid-19 virus infection - paxlovid is indicated for the treatment of coronavirus disease 2019 (covid-19) in adults who do not require supplemental oxygen and who are at increased risk for progressing to severe covid 19.
hexasoptin retard 240 mg depotkapsler, hårde
sandoz a/s - verapamilhydrochlorid - depotkapsler, hårde - 240 mg
isoptin retard 180 mg depottabletter
viatris aps - verapamilhydrochlorid - depottabletter - 180 mg
isoptin retard 180 mg depottabletter
paranova danmark a/s - verapamilhydrochlorid - depottabletter - 180 mg
isoptin retard 240 mg depottabletter
viatris aps - verapamilhydrochlorid - depottabletter - 240 mg